Innovation in Psychosis Therapeutics Summit
The Innovation in Psychosis Therapeutics Summit is the leading industry event driving the next generation of psychosis drug development. As 2025 unfolds, we are witnessing pivotal clinical advancements and a growing momentum from key collaborations since 2024. This is the perfect moment for a dedicated forum to unite R&D scientists pioneering novel psychosis drug discovery and development.
Join us for the inaugural summit, where over 60 industry leaders across discovery, preclinical, translational, and clinical development will collaborate to address the hurdles of psychosis treatment. With the rising unmet need for effective therapies and the significant side effects associated with atypical antipsychotics, now is the time to build on breakthrough successes like Cobenfy and drive the development of next-generation approaches targeting psychosis across the disease spectrum.
Discover cutting-edge tools and strategies for enhancing translational validity, predicting therapeutic efficacy, and streamlining the regulatory path for new treatments. Connect directly with key stakeholders and engage in structured networking sessions to forge meaningful connections that will accelerate progress in psychosis R&D.
Don’t miss this unique opportunity to be at the forefront of psychosis therapeutics and help shape the future of treatment across CNS disorders.
